academic article

• Iohexol Transmembrane Clearance during Modeled Continuous Renal Replacement Therapy..  Blood purification.  39:188-192. 2015
• Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model..  Clinical therapeutics.  36:1334-1344. 2014
• Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System..  Clinical toxicology (Philadelphia, Pa.).  51:96-105. 2013
• Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose..  Hemodialysis international. International Symposium on Home Hemodialysis.  15:412-415. 2011
• Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis..  Critical care medicine.  39:19-25. 2011
• Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies..  Blood purification.  30:37-43. 2010
• Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase..  Pharmacotherapy.  30:-. 2010
• Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients..  Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.  19:145-152. 2009
• Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury..  Critical care (London, England).  12:-. 2008
• Ertapenem clearance during modeled continuous renal replacement therapy..  The International journal of artificial organs.  31:1027-1034. 2008